To monitor the occurrence of invasive Hib disease over time and to determine product-specific rates of invasive Hib disease within the monitored population.
The purpose of the study is to conduct surveillance for Hib disease. Prospective active population-based surveillance for invasive Hib disease, conducted by the Center for Disease Control and Prevention (CDC) Active Bacterial Core (ABCs) program within geographic regions currently representing 12% of the US population, will provide Hib case-occurrence (numerator) data. The ABCs program and the National Center for Health Statistics will provide annual estimates of the number of persons under surveillance, by age group, within the ABCs catchment area. Ongoing telephone sample surveys, conducted by M/A/R/C, a national sampling organization, will provide brand-specific vaccine exposure data by age group within the ABCs program catchment area at appropriate pre-specified intervals (denominator data).
Study Type
OBSERVATIONAL
Enrollment
20,830
0.5 mL, Intramuscular
The rate of invasive Hib disease among persons within the population monitored by the Active Bacterial Core surveillance program.
Time frame: Up to 6 years post vaccination
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Albany, California, United States
Unnamed facility
Martinez, California, United States
Unnamed facility
San Francisco, California, United States
Unnamed facility
Applewood, Colorado, United States
Unnamed facility
Aurora, Colorado, United States
Unnamed facility
Brighton, Colorado, United States
Unnamed facility
Castle Rock, Colorado, United States
Unnamed facility
Denver, Colorado, United States
Unnamed facility
Hartford, Connecticut, United States
Unnamed facility
Adamsville, Georgia, United States
...and 49 more locations